Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 6100 participants.

Also called NCT03635749

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 6,100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03635749
Other papers using this trial's data
  • CYP2C19 Genotype and Efficacy of Clopidogrel Initiated Between 24 to 72 Hours for Ischemic Stroke Stroke, 2025-11 DOI, PubMed 40964718
  • Clopidogrel and Aspirin Initiated Between 24 to 72 Hours for Mild Ischemic Stroke: A Subgroup Analysis of the INSPIRES Randomized Clinical Trial JAMA network open, 2024-09-03 DOI, PubMed 39240565, PMC11380102 PubMed links an erratum for this paper. Erratum: PMID 40198077 In the PMC Open Access subset under CC BY.
  • Does the Burden of CSVD Modify the Efficacy of Dual Antiplatelet Therapy?: A Post Hoc Analysis of the INSPIRES Trial Stroke, 2025-06 DOI, PubMed 40190261
  • Dual Antiplatelet Therapy and Immediate Intensive Statin in Mild Ischemic Stroke: A Randomized Trial Neurology, 2026-07-28 DOI, PubMed 42348803
  • Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack Journal of the American Heart Association, 2025-08-05 DOI, PubMed 40673545, PMC12449989 In the PMC Open Access subset under CC BY-NC-ND.
  • Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis Stroke, 2025-01 DOI, PubMed 39705390
  • Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke The New England journal of medicine, 2023-12-28 DOI, PubMed 38157499
  • Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack Neurology, 2024-10-08 DOI, PubMed 39270151
  • Effect of history of hypertension on efficacy of clopidogrel-aspirin in ischemic stroke International journal of stroke : official journal of the International Stroke Society, 2025-10 DOI, PubMed 40251953
  • Efficacy and Safety of Dual Antiplatelet Treatment up to 72 Hours in Acute Ischemic Stroke Stratified by Glycemic Status Annals of neurology, 2025-07 DOI, PubMed 39931900 PubMed links an erratum for this paper. Erratum: PMID 40231763
  • Efficacy and safety of clopidogrel and aspirin initiated within 72 hours after mild ischemic stroke or high-risk TIA by sex: a prespecified subgroup analysis of the INSPIRES trial Expert review of cardiovascular therapy, 2026-07 DOI, PubMed 42390058
  • Efficacy and safety of dual antiplatelet treatment up to 72 hours after mild ischemic stroke or transient ischemic attack in patients with established cardiovascular disease Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026-07 DOI, PubMed 42430849, PMC13382003 In the PMC Open Access subset under CC BY-NC-ND.
  • Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical Trial JAMA neurology, 2024-07-01 DOI, PubMed 38805216, PMC11134282 In the PMC Open Access subset under CC BY.
  • The effect of dual antiplatelet therapy in different patterns of watershed infarction: Subgroup analysis of the INSPIRES trial Cell reports. Medicine, 2026-02-17 DOI, PubMed 41650951, PMC12923951 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03635749. Randomized; quadruple masking; primary purpose treatment. Start 2018-09-17 (actual); primary completion 2023-01-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
Acronym
INSPIRES
Condition
Acute Stroke
Intervention (Drug)
Intensive antiplatelet
Intervention (Drug)
Standard antiplatelet
Intervention (Drug)
Immediate high-intensity statin
Intervention (Drug)
Delayed high-intensity statin
Lead sponsor
Beijing Tiantan Hospital (class: other)
Collaborator
Ministry of Science and Technology of the People´s Republic of China (class: other government)

Record details

Record id
cardio:ct-nct03635749
Content hash
4f92f9d088a5f21ff971827adef65e914901b1d5de187b39e9e98d74da72dd5b